Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OPPS identifies more Orphan Drugs for reimbursement

The Centers for Medicare & Medicaid Services (CMS) on Wednesday released its proposed 2004 Hospital Outpatient Prospective Payment System (OPPS) draft rule. The draft identified 11 total Orphan Drugs eligible for retrospective

Read the full 325 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE